BioSpace News Archive

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2020 corporate update call on Monday, August 17 th at 5:00 PM ET. The call will include updates on the company’s current core businesses, as well as an update on the company’s COVID-19 testing initiative. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Pre

Invacare Corporation to Participate in the 5 th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven” or the “Company”) announced that it entered into a $500 million non-dilutive term loan financing facility with Six

InnovHeart s.r.l. , a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing. Founded in 2015 by Giovanni Righini , a 30-year veteran of the heart valve industry, the company maintains offices outside Milan, Italy, and Boston, Massachusetts. Proceeds from the financing will be used to

Anderson will support the company’s response to the rapid need for remote site access and collaboration platforms

Innovative Regulatory Risk Advisors LLC is a certified minority owned business and SBA 8 firm that provides regulatory compliance, risk management and business advisory capabilities to B2Band B2G clientele in Banking and Financial Services, Healthcare, Government, Energy and Technology.

SK pharmteco Inc is pleased to announce that Joyce Fitzharris has been appointed General Manager, SK biotek Ireland.

Today, Vicarious Surgical announced the closing of an additional $13.2 million in capital, led by Philip Liang of E15 Capital

RedHill Biopharma Ltd. (Nasdaq: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it will report its second quarter 2020 financial results and business highlights on Thursday, August 13, 2020. The Company will host a conference call and webcast on Thursday, August 13, 2020 at 8:30 a.m. EDT , during which it will present key highlights for the second quarter of 2020, in

Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX: SHWZ) (“Schwazze " or “the Company”), today announced that it will host its second quarter 2020 conference call and webcast on Thursday, August 13, 2020 at 4:30 p.m. ET.